Freund John Gordon
Collegium Pharmaceutical, Inc. · Director
Freund John Gordon is listed in filings as Director at Collegium Pharmaceutical, Inc.. This profile follows SEC Form 4 activity through May 20, 2026, including sale activity. Recent filings connect the profile to Collegium Pharmaceutical, Inc. (COLL) and SI-BONE, Inc. (SIBN). The current snapshot covers public activity from Jun 27, 2024 to May 20, 2026. Reported amounts are shown as $681 to $142.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $143k4.1k shares | SellMay 15, 2026 | $34.54 | $36.27 | |
| $401k11.7k shares | SellAug 8, 2025 | $34.36 | $36.27 | |
| $194k12.1k shares | SellAug 8, 2025 | $15.99 | $17.72 | |
| $202k6.6k shares | SellJun 9, 2025 | $30.62 | $36.27 |